Your browser doesn't support javascript.
loading
Research Progress in the Treatment of Infantile Hemangiomas by Propranolol / 中国药师
China Pharmacist ; (12): 670-672, 2014.
Article en Zh | WPRIM | ID: wpr-448065
Biblioteca responsable: WPRO
ABSTRACT
Objective:Infantile hemangiomas is the most common tumor in infants with congenital benign endothelial cell prolifera-tion. Propranolol is a non-selectiveβ-blocker commonly used in the treatment of arrhythmia, angina and hypertension, etc. Propranolol used in the treatment of hemangiomas was an accidental discovery, which creates a trend of research on the classic old drug at home and abroad. The efficacy of propranolol in the treatment of infantile hemangiomas has been affirmed in the clinical observation;howev-er, the safety and safe dosage need to be further evaluated by large sample control studies.
Palabras clave
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: China Pharmacist Año: 2014 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Idioma: Zh Revista: China Pharmacist Año: 2014 Tipo del documento: Article